Heavy Moat Investments
Subscribe
Sign in
Home
Podcast
Notes
Chat
Portfolio Updates
Deep Dive - Business Model
Deep Dive - Fundamentals
Earnings
Strategy
Quick Pitches
All Deep Dives
Archive
Leaderboard
About
All Deep Dives
Latest
Top
Discussions
The Stock Exchange Business model primer
How they work, where they win and what makes them interesting investments
Oct 13
•
Heavy Moat Investments
12
1
Ashtead Technology vs. Ashtead Group: Similar name, different game
Diving (pun intended) into the equipment rental industry
Oct 6
•
Heavy Moat Investments
4
1
Danaher: From Star Performer to Post-Pandemic Hangover
For years, Danaher stood at the center of secular growth narratives in biotech and diagnostics.
Sep 24
•
Heavy Moat Investments
9
Cellebrite: Benefiting from rising digital crime in a structurally underpenetrated market
Industry expected to grow by 15% with multiple secular tailwinds
Sep 3
•
Heavy Moat Investments
6
1
Cellebrite: Dominating digital Forensics ( Growth plus special situation)
Developing the picks and shovels of digital crime fighting
Aug 25
•
Heavy Moat Investments
6
3
Mettler-Toledo: A long-term winner in consolidation for 4 years
Can they return to outperformance again?
Jul 28
•
Heavy Moat Investments
3
1
Mettler Toledo: A Quiet Giant in Precision Instruments
Analyzing Mettler Toledo: Quality, Moat and Management
Jul 21
•
Heavy Moat Investments
9
1
Eurofins Scientific: Can this Elite compounder get back to outperforming?
Despite its three year bear market the company delivered a 28% CAGR over the last 25 years.
Jun 24
•
Heavy Moat Investments
9
3
Eurofins Scientific: A global leader in a secular growth industry at a discount
23% 27 year CAGR, despite its current 50% drawdown
Jun 5
•
Heavy Moat Investments
14
1
Eckert & Ziegler: A Pick-and-Shovel Play on Radiopharmaceuticals
Why Eckert & Ziegler could be one of the most overlooked compounders in Europe
Apr 14
•
Heavy Moat Investments
8
4
Pluxee: A wonderful business in a punished industry
Join Me and The Dutch Investors for a Deep Dive into Pluxee
Apr 12
•
Heavy Moat Investments
and
The Dutch Investors
6
1
2
59:50
IDEXX Laboratories: Quiet Compounder or Overlooked Opportunity?
A Deep Dive into Its Revenue Model, Margins and Long-Term Potential
Mar 26
•
Heavy Moat Investments
12
3
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts